Category: Press Release - Page 154 - Psychedelic Alpha

Explore our new Pα+ Psychedelic Bill Tracker.

Read more about the article Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap’s Mental Health Technology

Mydecine Innovations Group Announces Filing of a Provisional Patent for Mindleap’s Mental Health Technology

Post published:February 17, 2021
Post category:Press Release

Read more about the article Field Trip Health Ltd. Reports Third Fiscal Quarter 2021 Financial Results

Field Trip Health Ltd. Reports Third Fiscal Quarter 2021 Financial Results

Post published:February 16, 2021
Post category:Press Release

Read more about the article Alberta’s First Full-Service Psychedelic Therapy Clinic Opens in Calgary, Ushering in a New Era of Hope to Deal with the Growing Mental Health Crisis in Canada

Alberta’s First Full-Service Psychedelic Therapy Clinic Opens in Calgary, Ushering in a New Era of Hope to Deal with the Growing Mental Health Crisis in Canada

Post published:February 16, 2021
Post category:Press Release

Read more about the article Entheon Biomedical Hires Chief Business Officer; Senior Pharma Executive Dr. Brian Jahns to Oversee Business Development

Entheon Biomedical Hires Chief Business Officer; Senior Pharma Executive Dr. Brian Jahns to Oversee Business Development

Post published:February 16, 2021
Post category:Press Release

Read more about the article MINDCURE’s Proprietary Bioinformatics Platform, PsyCollage, Beta Tested and Deployed for Product Discovery and Lead Optimization

MINDCURE’s Proprietary Bioinformatics Platform, PsyCollage, Beta Tested and Deployed for Product Discovery and Lead Optimization

Post published:February 16, 2021
Post category:Press Release

Read more about the article Tryp Therapeutics Reaches Milestone on Psilocybin Drug Manufacturing Program

Tryp Therapeutics Reaches Milestone on Psilocybin Drug Manufacturing Program

Post published:February 16, 2021
Post category:Press Release

Read more about the article Mydecine Innovations Group Announces Closing of $17,250,000 Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option

Mydecine Innovations Group Announces Closing of $17,250,000 Bought-Deal Public Offering, Including Full Exercise of the Over-Allotment Option

Post published:February 12, 2021
Post category:Press Release

Read more about the article ATMA Launches Canada’s First Psychedelic Training Program for Mental Health Professionals that Includes a Legal Psychedelic Experience

ATMA Launches Canada’s First Psychedelic Training Program for Mental Health Professionals that Includes a Legal Psychedelic Experience

Post published:February 12, 2021
Post category:Press Release

Read more about the article MINDCURE Announces Listing of Warrants

MINDCURE Announces Listing of Warrants

Post published:February 11, 2021
Post category:Press Release

Read more about the article PharmaDrug Files for FDA Orphan Drug Designation for DMT in Stroke

PharmaDrug Files for FDA Orphan Drug Designation for DMT in Stroke

Post published:February 11, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.